Cognito Therapeutics

Cognito is a clinical-stage company dedicated to developing novel digital therapies with a proprietary neuromodulation platform. The core approach is a non-invasive neural stimulation that induces gamma oscillations in the brain, stimulating neuronal link remodeling, thereby improving neurodegenerative diseases such as Alzheimer's.